Leveraging a cuproptosis-based signature to predict the prognosis and drug sensitivity of cutaneous melanoma

Overview of attention for article published in Journal of Translational Medicine, January 2023

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 6 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 197 followers.

Leveraging a cuproptosis-based signature to predict the prognosis and drug sensitivity of cutaneous melanoma. https://t.co/R1fwZWsYIn https://t.co/v1nZ9yyfZ4

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.